Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksMARKSANS
resources
MARKSANS

Marksans Pharma Ltd.

NSE: MARKSANS
BSE: 524404
Sector: Healthcare
Industry: Pharmaceuticals
335.90+0.8 (+0.25%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Marksans Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Marksans Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Newspaper Publication7 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication regarding transfer of unclaimed dividend and equity shares of the Company to the IEPF
  2. Analyst / Investor Meet1 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of Investors Meet
  3. General27 Aug 2026
    Voting Results Of The 34Th Annual General Meeting Of The Company
    Please find attached the voting result of the 34th AGM
  4. AGM27 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrutinizer''s Report along with voting result for the 34th AGM
  5. AGM27 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceeding of 34th Annual General Meeting of the Company held today
  6. General26 Aug 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Please find attached disclosure on ESG rating
  7. Analyst / Investor Meet13 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of investor(s)/analyst(s) meet Conference Call on Q1 FY 27 Financial Results
  8. Newspaper Publication13 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication for Unaudited Financial Results for the quarter ended June 30, 2026
  9. Press Release / Media Release12 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release for Financial Results Q1 FY 27
  10. Outcome of Board Meeting12 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On 12 August 2026
    The Board in its meeting held on 12 August 2026 approved the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, 2026
  11. Newspaper Publication6 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find attached newspaper publication for Annual General Meeting Notice
  12. Business Responsibility and Sustainability Reporting (BRSR)4 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Please find enclosed the BRSR
  13. Reg. 34 (1) Annual Report4 Aug 2026
    Reg. 34 (1) Annual Report.
    Please find attached herewith the Annual Report for the Financial Year 2025-26
  14. AGM4 Aug 2026
    Shareholders Annual General Meeting To Be Held On August 27, 2026
    Notice of the 34th Annual General Meeting of the Company proposed to be held on 27 August 2026
  15. Analyst / Investor Meet3 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule for Q1FY27 Earnings Conference Call
  16. Board Meeting31 Jul 2026
    Board Meeting Intimation for Board Meeting Intimation For Declaration Of Quarterly Results For The Quarter Ended June 30, 2026
    Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Quarterly Results For The Quarter ....
  17. Newspaper Publication30 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication for AGM Intimation
  18. General20 Jul 2026
    Announcement Under Regulation 30 (LODR)- Updates
    Update on acquisition of 100 percent share capital of ABCnow GmbH.
  19. General17 Jul 2026
    DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"
    Second 100 Day Campaign - "Saksham Niveshak" Phase IV
  20. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026

Frequently Asked Questions

Where can I download the annual report of Marksans Pharma Ltd.?
Annual reports of Marksans Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Marksans Pharma Ltd.?
Quarterly earnings results and presentations of Marksans Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Marksans Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Marksans Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Marksans Pharma Ltd.?
Investor presentations and annual day presentations of Marksans Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Marksans Pharma Ltd.?
Corporate announcements and regulatory filings of Marksans Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Marksans Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Marksans Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Marksans Pharma Ltd.?
The ISIN (International Securities Identification Number) of Marksans Pharma Ltd. is INE750C01026. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Marksans Pharma Ltd. listed?
Marksans Pharma Ltd. is listed on NSE and BSE. The NSE symbol is MARKSANS and the BSE code is -.
Where can I find the shareholding pattern of Marksans Pharma Ltd.?
The quarterly shareholding pattern of Marksans Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Marksans Pharma Ltd. on Sharpely?
Share price data for Marksans Pharma Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.